Who to call at Lipella Pharmaceuticals, and when
Fundz watches for the moments Lipella Pharmaceuticals starts buying, and tells you who to reach.
- An alert the day Lipella Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lipella Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lipella Pharmaceuticals. With Fundz connected, it knows.
Lipella Pharmaceuticals Closes $1.28 Million Direct Offering of Common Stock Under Nasdaq Rules
Contract Type
agreement
Description
Lipella Pharmaceuticals Inc. has closed a registered direct offering priced at-the-market under Nasdaq rules, generating approximately $1.28 million in gross proceeds. The net proceeds from the offering will be allocated towards working capital and general corporate purposes.
Quick answer
Lipella Pharmaceuticals Closes $1.28 Million Direct Offering of Common Stock Under Nasdaq Rules (August 1, 2024). Lipella Pharmaceuticals is based in Pittsburgh, Pennsylvania, United States.
- What agreement did Lipella Pharmaceuticals announce on August 1, 2024?
- Lipella Pharmaceuticals Inc. has closed a registered direct offering priced at-the-market under Nasdaq rules, generating approximately $1.28 million in gross proceeds. The net proceeds from the offering will be allocated towards working capital and general corporate purposes.
- What does Lipella Pharmaceuticals do?
- Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well...
- Where is Lipella Pharmaceuticals based?
- Lipella Pharmaceuticals is based in Pittsburgh, Pennsylvania, United States.
Source: Fundz verified event record.
Related People
Lipella Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.